doi: 10.1016/j.jhep.2008.03.011
In phase II trials focusing on dermal applications, TB-500 has displayed promising outcomes for patients with pressure ulcers, stasis ulcers, and epidermolysis bullosa
Kabil O, Yadav V, and Banerjee R
Topical application through cream or serum can work for localized skin improvements, but absorption is limited, concentrations in commercial products are often insufficient, and youre not getting systemic effects that benefit hair follicles, internal wound healing, or broader tissue remodeling
It promotes dendritic spine formation and increases synaptic connectivity in preclinical models of neural development
Inject Monday through Friday, rest on weekends